See organizers’ website for details and registration.
Artificial intellegence is widely predicted to make drug discovery and patient diagnosis quicker, cheaper and more effective in the future, and signs of this can already be seen. AI has the potential to expedite the clinical drug discovery and development process by applying sophisticated algorithms to the analysis and mining of different data sources to predict molecule behavior and suitability as drug targets or therapeutic entities. McKinsey estimates that big data and machine learning in pharma and medicine could generate up to $100bn annually, based on better decision-making, optimised innovation, improved efficiency of research, clinical trials, and new tool creation for all stakeholders. This info-session organised by PIEP will cover different approaches and AI platforms, and how they will impact the pharmaceutical industry and specifically, the drug discovery and development processes. Join us to learn more about how these companies operate, what their objectives are and how you can get involved (there will be an hour of networking and several are hiring!). Food and drinks (alcoholic and non-alcoholic) will be provided during the networking section.
Food & Drinks provided!
6:00 – 7:00 PM – Scientific Talks
7:00 – 7:30 PM – Panel Discussion
7:30 – 8:30 PM – Networking & Dinner